BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

9572 related articles for article (PubMed ID: 10928109)

  • 1. Retargeting of a T cell line by anti MAGE-3/HLA-A2 alpha beta TCR gene transfer.
    Calogero A; Hospers GA; Krüse KM; Schrier PI; Mulder NH; Hooijberg E; de Leij LF
    Anticancer Res; 2000; 20(3A):1793-9. PubMed ID: 10928109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Redirecting human CD4+ T lymphocytes to the MHC class I-restricted melanoma antigen MAGE-A1 by TCR alphabeta gene transfer requires CD8alpha.
    Willemsen R; Ronteltap C; Heuveling M; Debets R; Bolhuis R
    Gene Ther; 2005 Jan; 12(2):140-6. PubMed ID: 15496961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved expression and reactivity of transduced tumor-specific TCRs in human lymphocytes by specific silencing of endogenous TCR.
    Okamoto S; Mineno J; Ikeda H; Fujiwara H; Yasukawa M; Shiku H; Kato I
    Cancer Res; 2009 Dec; 69(23):9003-11. PubMed ID: 19903853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous generation of CD8+ and CD4+ melanoma-reactive T cells by retroviral-mediated transfer of a single T-cell receptor.
    Roszkowski JJ; Lyons GE; Kast WM; Yee C; Van Besien K; Nishimura MI
    Cancer Res; 2005 Feb; 65(4):1570-6. PubMed ID: 15735047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phage display selected fab fragment with MHC class I-restricted specificity for MAGE-A1 allows for retargeting of primary human T lymphocytes.
    Willemsen RA; Debets R; Hart E; Hoogenboom HR; Bolhuis RL; Chames P
    Gene Ther; 2001 Nov; 8(21):1601-8. PubMed ID: 11894998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A fast and robust method to clone and functionally validate T-cell receptors.
    Birkholz K; Hofmann C; Hoyer S; Schulz B; Harrer T; Kämpgen E; Schuler G; Dörrie J; Schaft N
    J Immunol Methods; 2009 Jul; 346(1-2):45-54. PubMed ID: 19427315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a MAGE-1-derived HLA-A24 epitope-specific CTL line from a Japanese metastatic melanoma patient.
    Akiyama Y; Maruyama K; Tai S; Komiyama M; Iizuka A; Takikawa M; Ohshita C; Yamamoto A; Yamazaki N; Kiyohara Y; Yamaguchi K
    Anticancer Res; 2009 Feb; 29(2):647-55. PubMed ID: 19331215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alphabeta T-cell receptor engineered gammadelta T cells mediate effective antileukemic reactivity.
    van der Veken LT; Hagedoorn RS; van Loenen MM; Willemze R; Falkenburg JH; Heemskerk MH
    Cancer Res; 2006 Mar; 66(6):3331-7. PubMed ID: 16540688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient induction of cytotoxic T lymphocytes specific to hepatocellular carcinoma using HLA-A2-restricted MAGE-n peptide in vitro.
    Dong HL; Sui YF; Li ZS; Qu P; Wu W; Ye J; Zhang XM; Lu SY
    Cancer Lett; 2004 Aug; 211(2):219-25. PubMed ID: 15219945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MAGE-1-specific precursor cytotoxic T-lymphocytes present among tumor-infiltrating lymphocytes from a patient with breast cancer: characterization and antigen-specific activation.
    Toso JF; Oei C; Oshidari F; Tartaglia J; Paoletti E; Lyerly HK; Talib S; Weinhold KJ
    Cancer Res; 1996 Jan; 56(1):16-20. PubMed ID: 8548758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term phenotypic, functional and genetic stability of cancer-specific T-cell receptor (TCR) alphabeta genes transduced to CD8+ T cells.
    Hiasa A; Hirayama M; Nishikawa H; Kitano S; Nukaya I; Yu SS; Mineno J; Kato I; Shiku H
    Gene Ther; 2008 May; 15(9):695-9. PubMed ID: 18288212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid alphabeta TCR-mediated responses in gammadelta T cells transduced with cancer-specific TCR genes.
    Hiasa A; Nishikawa H; Hirayama M; Kitano S; Okamoto S; Chono H; Yu SS; Mineno J; Tanaka Y; Minato N; Kato I; Shiku H
    Gene Ther; 2009 May; 16(5):620-8. PubMed ID: 19242528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TCR reconstitution in Jurkat reporter cells facilitates the identification of novel tumor antigens by cDNA expression cloning.
    Aarnoudse CA; Krüse M; Konopitzky R; Brouwenstijn N; Schrier PI
    Int J Cancer; 2002 May; 99(1):7-13. PubMed ID: 11948485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reconstitution of anti-HIV effector functions of primary human CD8 T lymphocytes by transfer of HIV-specific alphabeta TCR genes.
    Ueno T; Fujiwara M; Tomiyama H; Onodera M; Takiguchi M
    Eur J Immunol; 2004 Dec; 34(12):3379-88. PubMed ID: 15517606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The anti-tumor immune response induced by a combination of MAGE-3/MAGE-n-derived peptides.
    Zhang XM; Zhang YF; Huang Y; Qu P; Ma B; Si SY; Li ZS; Li WX; Li X; Ge W; Hu PZ; Sui YF
    Oncol Rep; 2008 Jul; 20(1):245-52. PubMed ID: 18575744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual HLA class I and class II restricted recognition of alloreactive T lymphocytes mediated by a single T cell receptor complex.
    Heemskerk MH; de Paus RA; Lurvink EG; Koning F; Mulder A; Willemze R; van Rood JJ; Falkenburg JH
    Proc Natl Acad Sci U S A; 2001 Jun; 98(12):6806-11. PubMed ID: 11381117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fine structural variations of alphabetaTCRs selected by vaccination with natural versus altered self-antigen in melanoma patients.
    Wieckowski S; Baumgaertner P; Corthesy P; Voelter V; Romero P; Speiser DE; Rufer N
    J Immunol; 2009 Oct; 183(8):5397-406. PubMed ID: 19786555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melanoma patients respond to a cytotoxic T lymphocyte-defined self-peptide with diverse and nonoverlapping T-cell receptor repertoires.
    Dietrich PY; Walker PR; Quiquerez AL; Perrin G; Dutoit V; Liénard D; Guillaume P; Cerottini JC; Romero P; Valmori D
    Cancer Res; 2001 Mar; 61(5):2047-54. PubMed ID: 11280765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Grafting primary human T lymphocytes with cancer-specific chimeric single chain and two chain TCR.
    Willemsen RA; Weijtens ME; Ronteltap C; Eshhar Z; Gratama JW; Chames P; Bolhuis RL
    Gene Ther; 2000 Aug; 7(16):1369-77. PubMed ID: 10981663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of specific CTL by MAGE-3/CEA peptide-pulsed dendritic cells from HLA-A2/A24(+) gastrointestinal cancer patients.
    Hao X; Shao Y; Ren X; Liu H; Xu Q; Li H; Zhang P; An X; Ren B
    J Cancer Res Clin Oncol; 2002 Sep; 128(9):507-15. PubMed ID: 12242516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 479.